The nation of Zimbabwe has declined a substantial US health deal valued at 367 million US dollars (£272m) spanning five years because of the United States' request for confidential data.
This move was revealed following a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson has since explained that the US was seeking biological samples for research and commercial purposes while was not willing to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more dialogue to secure a deal suitable to both sides so the country's vital HIV programme can continue.
Wider Context
This rejection follows a similar situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to boost openness and accountability.
According to statements, 16 African countries have so far agreed to similar agreements, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"In essence, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our population if a future health crisis emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures already established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a country provides its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to continued dialogue with our American counterparts on how future collaboration might be arranged in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations should continue considering much of the nation's Aids initiatives relied on foreign aid.
"If technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it added.
The situation emphasises the continuing tensions between receiving crucial foreign assistance and safeguarding a country's data in an ever more data-driven world.